Related Experiment Video

Updated: Jun 5, 2026

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

Biliary disease in children

Matthew Goldman1, Thomas Pranikoff

  • 1Department of Surgery, Section of Pediatric Surgery, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. mgoldman@wfubmc.edu

Current Gastroenterology Reports
|January 13, 2011
PubMed

Insights

Pediatric biliary diseases like biliary atresia and choledochal cysts are rare but serious. Early diagnosis and treatment are crucial to reduce high morbidity and mortality rates in children.

Area of Science:

  • Pediatric gastroenterology and hepatology.
  • Clinical diagnostics in pediatric medicine.

Background:

  • Biliary diseases in children are uncommon but can lead to severe complications.
  • Accurate diagnosis is challenging due to overlapping symptoms across various conditions.
  • Timely intervention is critical for improving patient outcomes.

Purpose of the Study:

  • To review the epidemiology of four key pediatric biliary diseases.
  • To outline diagnostic approaches for differentiating these conditions.
  • To discuss treatment strategies and prognosis for improved patient care.

Main Methods:

  • Review of current literature on pediatric biliary diseases.
  • Analysis of diagnostic criteria and challenges.
  • Summary of established and emerging treatment modalities.

Main Results:

  • Biliary atresia, choledochal cysts, gallbladder disease, and Alagille syndrome present with similar clinical, laboratory, and radiographic findings.
  • Accurate differentiation is essential as treatment varies significantly.
  • Effective management can substantially decrease morbidity and mortality.

Conclusions:

  • Prompt and accurate diagnosis of pediatric biliary diseases is paramount.
  • Understanding the nuances of each condition guides appropriate therapeutic decisions.
  • Integrated management strategies are key to mitigating long-term complications.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Bile01:19

Bile

Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...